Tag: Dr Christian Behrenbruch
Telix to acquire RLS in major expansion of North American manufacturing and distribution platform
Telix Pharmaceuticals announced its agreement to acquire RLS (USA) Inc, the only Joint Commission-accredited radiopharmacy network in the US, as part of a strategic move to expand its North American manufacturing and distribution capabilities.
Telix ventures into advanced isotope production with ARTMS acquisition
Telix Pharmaceuticals Limited has entered into an agreement to acquire radioisotope production technology firm ARTMS Inc, its advanced cyclotron-based isotope production platform, manufacturing plant, and stockpile of ultra-pure rare metals required for consumable target production.
Telix Pharmaceuticals expands US manufacturing ops with IsoTherapeutics acquisition
Telix Pharmaceuticals Limited announced its agreement to acquire IsoTherapeutics Group, a specialty radiopharmaceutical development and bioconjugation firm headquartered in Angleton, Texas.
Featured Article
The economic forces driving manufacturing’s next cycle
Australia’s manufacturing sector entered 2026 with improving momentum, but renewed global disruption is again testing resilience across the industry.
